Author:
Fresa Kyle,Catandi Giovana D.,Whitcomb Luke,Gonzalez-Castro Raul A.,Chicco Adam J.,Carnevale Elaine M.
Abstract
AbstractObesity is a complex disease associated with augmented risk of metabolic disorder development and cellular dysfunction in various species. The goal of the present study was to investigate the impacts of obesity on the metabolic health of old mares as well as test the ability of diet supplementation with either a complex blend of nutrients designed to improve equine metabolism and gastrointestinal health or L-carnitine alone to mitigate negative effects of obesity. Mares (n = 19, 17.9 ± 3.7 years) were placed into one of three group: normal-weight (NW, n = 6), obese (OB, n = 7) or obese fed a complex diet supplement for 12 weeks (OBD, n = 6). After 12 weeks and completion of sample collections, OB mares received L-carnitine alone for an additional 6 weeks. Obesity in mares was significantly associated with insulin dysregulation, reduced muscle mitochondrial function, and decreased skeletal muscle oxidative capacity with greater ROS production when compared to NW. Obese mares fed the complex diet supplement had better insulin sensivity, greater cell lipid metabolism, and higher muscle oxidative capacity with reduced ROS production than OB. L-carnitine supplementation alone did not significantly alter insulin signaling, but improved lipid metabolism and muscle oxidative capacity with reduced ROS. In conclusion, obesity is associated with insulin dysregulation and altered skeletal muscle metabolism in older mares. However, dietary interventions are an effective strategy to improve metabolic status and skeletal muscle mitochondrial function in older mares.
Funder
Cecil and Irene Hylton Foundation
Abney Foundation Scholarship
Foundation for the Horse
USDA National Institute of Food and Agriculture Animal Health and Disease
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Giles, S. L., Rands, S. A., Nicol, C. J. & Harris, P. A. Obesity prevalence and associated risk factors in outdoor living domestic horses and ponies. PeerJ 2, e299 (2014).
2. Kosolofski, H. R., Gow, S. P. & Robinson, K. A. Prevalence of obesity in the equine population of Saskatoon and surrounding area. Can. Vet. J. 58
3. Ertelt, A., Barton, A.-K., Schmitz, R. R. & Gehlen, H. Metabolic syndrome: Is equine disease comparable to what we know in humans?. Endocr. Connect. 3, R81–R93 (2014).
4. Rendle, D. et al. Equine obesity: current perspectives. UK-Vet. Equine 2, 1–19 (2018).
5. Johnson, P. J., Wiedmeyer, C. E., LaCarrubba, A., Ganjam, V. K. S. & Messer, N. T. Diabetes, insulin resistance, and metabolic syndrome in horses. J. Diabetes Sci. Technol. 6, 534–540 (2012).